Search for: "Doe v. Abbott Laboratories" Results 1 - 20 of 205
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 May 2024, 6:39 am by Rebecca Tushnet
Abbott Laboratories, No. 22-CV-5435 (RER) (JRC), 2024 WL 2022297 (E.D.N.Y. [read post]
19 Jan 2024, 4:00 am by Alan Macek
The approach in [Abbott Laboratories v Canada (Minister of Health), 2009 FC 648] suggests that where an inventor can trace the origin of the divisional back to the forced divisional application it will be immune from double patenting attacks. [read post]
22 Nov 2023, 6:44 am by Daniel J. Gilman
(I’m here; my Manne is here, and here with Lazar Radic; former FTC General Counsel Alden Abbott says that the FTC’s complaint is “Perhaps the Greatest Affront to Consumer and Producer Welfare in Antitrust History” here). [read post]
11 Sep 2023, 4:00 am by Administrator
Canadian Securities Law Canadian Class Actions MonitorSaskatchewan Court of Appeal: Serial Certification Attempts Abusive In Abbott Laboratories, Ltd. v Spicer, the Saskatchewan Court of Appeal permanently stayed a proposed class action that was the last of five proposed national class actions concerning the drug sibutramine. [read post]
12 Mar 2023, 9:05 pm by Richard J. Pierce, Jr.
How does the FTC interpret Section 7 of the Clayton Act under Khan’s leadership and what analytical steps will the FTC take to determine whether a proposed transaction is legal? [read post]
28 Nov 2022, 4:45 pm by Samuel Bray
Although vacatur would have been highly relevant in Abbott Laboratories, that remedy does not appear in the opinions in that case. [read post]
28 Apr 2022, 4:17 pm by Coral Beach
The discovery of the five types of cronobacter does however, suggest an ongoing problem at the facility and not just a single incident. [read post]
28 Mar 2022, 12:50 am by Kristi L. Wolff and Jaclyn M. Metzinger
This month’s update kicks off spring with a Best in Show throwback ad comparing dog flea and tick medication, pivots to claims for survivalist ready-to-eat meals (don’t even try to act like you saw that coming), highlights FDA’s recently-issued voluntary recall guidance, provides a food court update on the latest ingredient class actions and cleans up with a pet food win in the Tenth Circuit on “fresh” and “regional” claims. [read post]
23 Aug 2021, 2:12 am by Radhi Shah (USC Gould School of Law)
Congress, to exercise March-in rights for patents owned by Abbott laboratories, Inc. [read post]
9 Jan 2021, 2:00 pm by Robert Liles
  Nevertheless, just because a certain treatment regime is medically necessary does not mean that it will be covered by one or more payors. [read post]